Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications
- PMID: 38408962
- PMCID: PMC10895768
- DOI: 10.1186/s12929-024-01013-w
Metabolism-regulating non-coding RNAs in breast cancer: roles, mechanisms and clinical applications
Abstract
Breast cancer is one of the most common malignancies that pose a serious threat to women's health. Reprogramming of energy metabolism is a major feature of the malignant transformation of breast cancer. Compared to normal cells, tumor cells reprogram metabolic processes more efficiently, converting nutrient supplies into glucose, amino acid and lipid required for malignant proliferation and progression. Non-coding RNAs(ncRNAs) are a class of functional RNA molecules that are not translated into proteins but regulate the expression of target genes. NcRNAs have been demonstrated to be involved in various aspects of energy metabolism, including glycolysis, glutaminolysis, and fatty acid synthesis. This review focuses on the metabolic regulatory mechanisms and clinical applications of metabolism-regulating ncRNAs involved in breast cancer. We summarize the vital roles played by metabolism-regulating ncRNAs for endocrine therapy, targeted therapy, chemotherapy, immunotherapy, and radiotherapy resistance in breast cancer, as well as their potential as therapeutic targets and biomarkers. Difficulties and perspectives of current targeted metabolism and non-coding RNA therapeutic strategies are discussed.
Keywords: Amino acid metabolism; Breast cancer; Glycolysis; Lipid metabolism; Metabolism; Non-coding RNAs.
© 2024. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures





Similar articles
-
The emerging regulatory roles of non-coding RNAs associated with glucose metabolism in breast cancer.Semin Cancer Biol. 2023 Oct;95:1-12. doi: 10.1016/j.semcancer.2023.06.007. Epub 2023 Jun 25. Semin Cancer Biol. 2023. PMID: 37364663 Review.
-
Non-coding RNAs: Key regulators of aerobic glycolysis in breast cancer.Life Sci. 2020 Jun 1;250:117579. doi: 10.1016/j.lfs.2020.117579. Epub 2020 Mar 21. Life Sci. 2020. PMID: 32209425 Review.
-
Non-coding RNAs in the reprogramming of glucose metabolism in cancer.Cancer Lett. 2018 Apr 10;419:167-174. doi: 10.1016/j.canlet.2018.01.048. Epub 2018 Jan 31. Cancer Lett. 2018. PMID: 29366802 Review.
-
The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.Int J Cancer. 2022 Aug 1;151(3):337-347. doi: 10.1002/ijc.34040. Epub 2022 May 11. Int J Cancer. 2022. PMID: 35460073 Free PMC article. Review.
-
Metabolic Pathways in Breast Cancer Reprograming: An Insight to Non-Coding RNAs.Cells. 2022 Sep 23;11(19):2973. doi: 10.3390/cells11192973. Cells. 2022. PMID: 36230935 Free PMC article. Review.
Cited by
-
Visfatin Facilitates VEGF-D-Induced Lymphangiogenesis through Activating HIF-1α and Suppressing miR-2277-3p in Human Chondrosarcoma.Int J Mol Sci. 2024 May 9;25(10):5142. doi: 10.3390/ijms25105142. Int J Mol Sci. 2024. PMID: 38791180 Free PMC article.
-
Regulatory Roles of miR-155-5p, miR-21-5p, miR-93-5p, and miR-140-5p in Breast Cancer Progression.Curr Issues Mol Biol. 2025 May 20;47(5):377. doi: 10.3390/cimb47050377. Curr Issues Mol Biol. 2025. PMID: 40699776 Free PMC article.
-
Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer.Mol Cancer. 2024 Nov 21;23(1):261. doi: 10.1186/s12943-024-02165-x. Mol Cancer. 2024. PMID: 39574178 Free PMC article. Review.
-
Circular RNAs as Biomarkers in Breast Cancer Diagnosis, Prognosis, Molecular Types, Metastasis and Drug Resistance.Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251328500. doi: 10.1177/15330338251328500. Epub 2025 Mar 13. Technol Cancer Res Treat. 2025. PMID: 40080898 Free PMC article. Review.
-
Non-metabolic enzyme function of pyruvate kinase M2 in breast cancer.Front Oncol. 2024 Oct 1;14:1450325. doi: 10.3389/fonc.2024.1450325. eCollection 2024. Front Oncol. 2024. PMID: 39411137 Free PMC article. Review.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–249. - PubMed
-
- Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321:288–300. - PubMed
-
- Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–674. - PubMed
-
- Paul S, Ghosh S, Kumar S. Tumor glycolysis, an essential sweet tooth of tumor cells. Semin Cancer Biol. 2022;86:1216–1230. - PubMed
-
- Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134:703–707. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- KJXW2020019/Suzhou Science, Education and Health Youth Science and Technology Project
- SKJY2021097/Science and Technology Program of Suzhou
- SKY2021045/Science and Technology Program of Suzhou
- 81702078/the National Natural Science Foundation of China
- 81901599/the National Natural Science Foundation of China
- BK20170356/the Natural Science Foundation of Jiangsu Province
- XKTJ-HRC2021001/Gusu Talent Program; Support for the project of nuclear technology medical application supported by discipline construction
- FYX202123/Maternal and Child Health Association Project of Jiangsu province
- Qngg2023008/"National Tutor System" Training Program for Health Youth Key Talents in Suzhou
LinkOut - more resources
Full Text Sources
Medical